The primary role played by NLRP3 inflammasome is also supported by evidence that genetic ablation of NLRP3–/– prevents the obesity-induced inflammasome activation in AT and protects against HFD-induced IR (Vandanmagsar et al., 2011). Here, NLRP3 is linked to obesity due to melanocortin 4 receptor deficiency.